Enanta Pharma (ENTA) Reports Positive Topline Results from Phase 2 SPRINT Trial of EDP-235

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. SPY
6. ACN
7. NVDA
8. PRIM
9. META
10. PFE

Go back to Enanta Pharma (ENTA) Reports Positive Topline Results from Phase 2 SPRINT Trial of EDP-235
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.75 +0.38 (2.84%)
Previous Close $13.37    52 Week High $34.49 
Open $13.22    52 Week Low $20.39 
Day High $14.12    P/E N/A 
Day Low $12.92    EPS $-3.18 
Volume 247,455